Medicine, at its most careful, resists the temptation to treat a feeling before understanding its cause. A major medical society has issued new guidelines on testosterone replacement therapy, reminding clinicians that fatigue and low libido are not diagnoses — they are invitations to look deeper. The guidance, grounded in recent large-scale trial data, asks physicians to hold two truths at once: that testosterone therapy can genuinely help men with confirmed hypogonadism, and that its long-term risks, including blood clots and uncertain prostate cancer implications, demand humility and vigilan